Indication
Drug-induced
4 clinical trials
5 products
1 drug
Clinical trial
Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium DiseaseStatus: Not yet recruiting, Estimated PCD: 2027-01-01
Product
ORC-13661Drug
VarlilumabClinical trial
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening: Reducing the Risk of Drug-Induced QT Interval Lengthening in WomenStatus: Completed, Estimated PCD: 2024-05-21
Product
ProgesteroneProduct
IbutilideClinical trial
Preventing Levodopa Induced Dyskinesia in Parkinson?s Disease With StatinsStatus: Recruiting, Estimated PCD: 2026-07-01
Product
Intravenous InfusionClinical trial
Novel Approaches for Minimizing Drug-Induced QT Interval LengtheningStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Testosterone